{"denomUnitsSelected":"Participants","description":"To determine efficacy of the candidate product, defined as establishment of \\> 5% mononuclear blood cells expressing anti-HIV genes","reportingStatus":"NOT_POSTED","timeFrame":"3 months post-transplant","title":"Proportion of Study Participants Who Achieve Greater Than 5% Mononuclear Blood Cells Expressing Anti-HIV Genes in Peripheral Blood","type":"SECONDARY"}